Reta ZPHC (Retatrutide) Powder

Reta ZPHC contains retatrutide, an investigational peptide being studied for its potential effects on weight management and metabolic health. It acts on three receptor pathways: GLP-1, GIP and glucagon, which are involved in appetite regulation, energy balance and glucose metabolism. Research has examined its potential effects on appetite, energy expenditure, body weight and blood sugar regulation.

Retatrutide remains investigational, and its safety and efficacy for routine use have not been fully established.

Product Format

Unlike a pre-filled pen, Reta ZPHC is supplied as powder in vials and is not a ready-to-use injection device. Product quality, sterility, purity and appropriate handling should not be assumed without reliable verification.

Precautions

• Retatrutide remains investigational; approval status and legal requirements vary by jurisdiction.

• Safety during pregnancy and breastfeeding has not been established.

• Potential adverse effects and long-term risks require further evaluation.

• For research use only: Not intended for human or veterinary use.